Cargando…

Serum neurofilament light as a predictor of outcome in subarachnoid haemorrhage

BACKGROUND: Prognostication of clinical outcome in patients suffering from aneurysmal subarachnoid haemorrhage (SAH) is a challenge. There are no biochemical markers in routine use that can aid in prognostication. Neurofilament light (NFL) measured in cerebrospinal fluid (CSF) has been associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Conny, Aineskog, Helena, Koskinen, Lars-Owe D., Gunnarsson, Andreas, Lindvall, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542720/
https://www.ncbi.nlm.nih.gov/pubmed/37351672
http://dx.doi.org/10.1007/s00701-023-05673-9
_version_ 1785114152929329152
author Johansson, Conny
Aineskog, Helena
Koskinen, Lars-Owe D.
Gunnarsson, Andreas
Lindvall, Peter
author_facet Johansson, Conny
Aineskog, Helena
Koskinen, Lars-Owe D.
Gunnarsson, Andreas
Lindvall, Peter
author_sort Johansson, Conny
collection PubMed
description BACKGROUND: Prognostication of clinical outcome in patients suffering from aneurysmal subarachnoid haemorrhage (SAH) is a challenge. There are no biochemical markers in routine use that can aid in prognostication. Neurofilament light (NFL) measured in cerebrospinal fluid (CSF) has been associated with clinical outcome in previous studies. OBJECTIVE: To investigate if serum levels of NFL correlate with CSF levels and long-term clinical outcome in patients suffering from SAH. METHODS: We conducted an observational cohort study of 88 patients treated for SAH at Umeå University Hospital in 2014–2018. Serum and CSF samples were analysed using an enzyme-linked immunosorbent assay to quantify NFL levels. Outcome was assessed using Glasgow Outcome Scale Extended and dichotomised as favourable or unfavourable. Differences in NFL levels between outcome groups were analysed using repeated measurements ANOVA. Relationship between CSF and serum NFL levels was analysed using Pearson’s correlation. A multivariate binary logistic regression model and a receiver operation characteristic curve were used to assess the predictive value of serum NFL. RESULTS: A significant correlation between serum and CSF-NFL levels could be seen (Pearson’s correlation coefficient = 0.7, p < .0001). Mean level of serum NFL was higher in the unfavourable outcome group than the favourable outcome group (p < .0001), in all epochs of SAH, and correlated with initial disease severity on the World Federation of Neurosurgical Societies scale. Serum NFL in the late phase displayed the best predictive potential in a receiver operation characteristic curve analysis (AUC=0.845, p < .0001). CONCLUSION: Levels of NFL in serum and CSF are correlated. Early serum NFL levels seem to reflect initial tissue damage and serum NFL levels in the late phase may reflect secondary events such as vasospasm or delayed cerebral ischemia. Serum NFL may be used as a prognostic marker of clinical outcome in SAH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00701-023-05673-9.
format Online
Article
Text
id pubmed-10542720
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-105427202023-10-03 Serum neurofilament light as a predictor of outcome in subarachnoid haemorrhage Johansson, Conny Aineskog, Helena Koskinen, Lars-Owe D. Gunnarsson, Andreas Lindvall, Peter Acta Neurochir (Wien) Original Article BACKGROUND: Prognostication of clinical outcome in patients suffering from aneurysmal subarachnoid haemorrhage (SAH) is a challenge. There are no biochemical markers in routine use that can aid in prognostication. Neurofilament light (NFL) measured in cerebrospinal fluid (CSF) has been associated with clinical outcome in previous studies. OBJECTIVE: To investigate if serum levels of NFL correlate with CSF levels and long-term clinical outcome in patients suffering from SAH. METHODS: We conducted an observational cohort study of 88 patients treated for SAH at Umeå University Hospital in 2014–2018. Serum and CSF samples were analysed using an enzyme-linked immunosorbent assay to quantify NFL levels. Outcome was assessed using Glasgow Outcome Scale Extended and dichotomised as favourable or unfavourable. Differences in NFL levels between outcome groups were analysed using repeated measurements ANOVA. Relationship between CSF and serum NFL levels was analysed using Pearson’s correlation. A multivariate binary logistic regression model and a receiver operation characteristic curve were used to assess the predictive value of serum NFL. RESULTS: A significant correlation between serum and CSF-NFL levels could be seen (Pearson’s correlation coefficient = 0.7, p < .0001). Mean level of serum NFL was higher in the unfavourable outcome group than the favourable outcome group (p < .0001), in all epochs of SAH, and correlated with initial disease severity on the World Federation of Neurosurgical Societies scale. Serum NFL in the late phase displayed the best predictive potential in a receiver operation characteristic curve analysis (AUC=0.845, p < .0001). CONCLUSION: Levels of NFL in serum and CSF are correlated. Early serum NFL levels seem to reflect initial tissue damage and serum NFL levels in the late phase may reflect secondary events such as vasospasm or delayed cerebral ischemia. Serum NFL may be used as a prognostic marker of clinical outcome in SAH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00701-023-05673-9. Springer Vienna 2023-06-23 2023 /pmc/articles/PMC10542720/ /pubmed/37351672 http://dx.doi.org/10.1007/s00701-023-05673-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Johansson, Conny
Aineskog, Helena
Koskinen, Lars-Owe D.
Gunnarsson, Andreas
Lindvall, Peter
Serum neurofilament light as a predictor of outcome in subarachnoid haemorrhage
title Serum neurofilament light as a predictor of outcome in subarachnoid haemorrhage
title_full Serum neurofilament light as a predictor of outcome in subarachnoid haemorrhage
title_fullStr Serum neurofilament light as a predictor of outcome in subarachnoid haemorrhage
title_full_unstemmed Serum neurofilament light as a predictor of outcome in subarachnoid haemorrhage
title_short Serum neurofilament light as a predictor of outcome in subarachnoid haemorrhage
title_sort serum neurofilament light as a predictor of outcome in subarachnoid haemorrhage
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542720/
https://www.ncbi.nlm.nih.gov/pubmed/37351672
http://dx.doi.org/10.1007/s00701-023-05673-9
work_keys_str_mv AT johanssonconny serumneurofilamentlightasapredictorofoutcomeinsubarachnoidhaemorrhage
AT aineskoghelena serumneurofilamentlightasapredictorofoutcomeinsubarachnoidhaemorrhage
AT koskinenlarsowed serumneurofilamentlightasapredictorofoutcomeinsubarachnoidhaemorrhage
AT gunnarssonandreas serumneurofilamentlightasapredictorofoutcomeinsubarachnoidhaemorrhage
AT lindvallpeter serumneurofilamentlightasapredictorofoutcomeinsubarachnoidhaemorrhage